Alkem Labs gets US FDA's nod to market generic of Azasan drug

Alkem Labs gets US FDA's nod to market generic of Azasan drug

The US Food and Drug Administration has given its consent to Alkem Laboratories Ltd to market Azathioprine tablets, an update on the drug regulator's website showed.

AgenciesUpdated: Wednesday, April 01, 2020, 10:23 AM IST
article-image

Azathioprine is a generic version of AAIPharma LLC's Azasan drug, used to prevent a patient's body from rejecting a transplanted kidney. Azathioprine is also used to treat symptoms of rheumatoid arthritis. Alkem's azathioprine drug will be available in 25-mg, 50-mg, 75-mg, and 100-mg strengths. At 0935 IST, shares of the drug maker were up nearly 1% at 2,345.20 rupees on the National Stock Exchange.

RECENT STORIES

Tech Mahindra Shares Rockets To Over 11% Even As Citi Maintains 'Sell' Rating

Tech Mahindra Shares Rockets To Over 11% Even As Citi Maintains 'Sell' Rating

RBI Announces Auction Sale of Govt. Securities Of Rs 32,000 Crore

RBI Announces Auction Sale of Govt. Securities Of Rs 32,000 Crore

Despite Drop In Profits, Tech Mahindra Shares Soar Over 9% As Indices Open In Green

Despite Drop In Profits, Tech Mahindra Shares Soar Over 9% As Indices Open In Green

Analysis: Jobless Growth – The Oxymoron Demystified

Analysis: Jobless Growth – The Oxymoron Demystified

Exciting Investment Opportunities Are Available, In The Capital Market

Exciting Investment Opportunities Are Available, In The Capital Market